Patent · US Active

Compound for treating or preventing hyperuricemia or gout

US10399971B2 · kind B2 · utility

1Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2016
Grant dateSep 3, 2019
Priority date
Expiry dateSep 9, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.